Table 4.
Two models of multivariate analyses of the association between clinical characteristics and the risk of ARDS or death in hemodialysis patients with SARS-CoV-2 infection
| Variable | Outcome: ARDS |
|
|---|---|---|
| OR (95% CI) | P value | |
| Model 1 | ||
| History of ischemic cardiac disease | 7.5 (1.6–36.3) | 0.04 |
| Fever at disease onset | 17 (4.5–64) | 0.0009 |
| Age at symptoms (>70 yr vs. ≤70 yr) | 1.1 (1–1.15) | 0.03 |
| Shortness of breath | 20 (3.6–79.3) | 0.004 |
| Myalgia or fatigue | 8.5 (0.83–40.3) | 0.11 |
| Variable | Outcome: death |
|
|---|---|---|
| OR (95% CI) | P value | |
| Model 2 | ||
| History of ischemic cardiac disease | 5 (0.94–32.3) | 0.07 |
| Fever at disease onset | 18.7 (2.4–146) | 0.02 |
| Cough at disease onset | 4 (1.02–17.6) | 0.05 |
| CRP at baseline (>50 mg/l vs. ≤50 mg/l) | 5.6 (1.6–23.5) | 0.01 |
Bold data refer to statistically significant P values.
ARDS, acute respiratory distress syndrome; CI, confidence interval; CRP, C-reactive protein; OR, odds ratio; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.